Grupo NC Executive and Leadership Team

Luciane Desiato, the Secretária Executiva Trilingue Chief Executive Officer at Grupo NC, directs the overarching corporate strategy and long-term vision for the organization. By aligning internal resources with the company's mission of providing innovative healthcare solutions, Desiato ensures consistent growth across both B2B and B2C pharmaceutical segments. The Chief Executive Officer manages high-level stakeholder relationships and oversees the expansion of market reach into diverse international territories, including the strategic push into Asian markets. Through rigorous oversight of corporate governance and performance metrics, Luciane Desiato maintains the competitive edge of the firm within the South American landscape. This leadership role involves constant evaluation of market trends to pivot the business model toward sustainable development. Ultimately, the Chief Executive Officer drives the organizational culture toward excellence, ensuring that every operational aspect reflects the core values of responsible innovation and continuous improvement.

Nicole Da Gama, the Chief Financial Officer, Executive Assistant at Grupo NC, oversees the fiscal health and capital allocation strategies of the organization. By managing financial planning and analysis, the Chief Financial Officer, Executive Assistant ensures that the company maintains the liquidity required for ongoing expansion into Asian markets. Da Gama directs the budgeting processes and monitors the financial performance of various business units to ensure alignment with corporate goals. Nicole Da Gama provides critical support to the executive leadership team by synthesizing complex financial data into actionable insights for strategic decision-making. This role involves the rigorous management of investment portfolios and the mitigation of financial risks associated with international pharmaceutical trade. Through the implementation of robust fiscal controls, the Chief Financial Officer, Executive Assistant supports the long-term sustainability of the firm. Ultimately, Da Gama secures the financial resources necessary to fuel continuous innovation and market impact.

Danieli Moralez, the Chief Operating Officer at Grupo NC, manages the daily operational workflows and logistics across the company's extensive manufacturing network. Focusing on the B2B and B2C service models, the Chief Operating Officer ensures seamless delivery of pharmaceutical products to diverse markets. Moralez directs the optimization of internal processes to reduce waste and enhance productivity within the factory environments. By coordinating with regional managers, Danieli Moralez maintains operational consistency throughout South American operations. This leadership position involves the rigorous monitoring of supply chain performance and the implementation of lean manufacturing principles to support sustainable growth. Through the oversight of daily business activities, the Chief Operating Officer guarantees that all operational outputs align with the company's commitment to excellence. Ultimately, Moralez drives the operational stability required to meet the increasing demand for high-quality healthcare solutions in both domestic and international markets.

Diego Neufert, the Chief Technology Officer at Grupo NC, architects the digital infrastructure and technical frameworks necessary for modern pharmaceutical manufacturing. Overseeing the integration of advanced automation within production facilities, the Chief Technology Officer ensures that all technical processes meet stringent quality standards. Neufert drives the adoption of cutting-edge research and development tools to accelerate the creation of new healthcare solutions. By managing the technological roadmap, Diego Neufert supports the company's expansion into global markets through scalable digital systems. This role requires close collaboration with the executive team to align technical capabilities with business objectives. Through the implementation of data-driven manufacturing protocols, the Chief Technology Officer optimizes production efficiency across the entire supply chain. Ultimately, Neufert secures the technological foundation that allows the firm to maintain a leading position in the highly competitive pharmaceutical industry.